Intuitive Surgical, Inc. (ISRG) has been navigating a corrective phase after reaching higher levels earlier in the year. The stock declined approximately 14% over the last 30 days but has staged a sharp rebound, rising over 2.4% in a recent session to close at $469.21. This price action reflects a break above short-term trendline support near $458-$460, suggesting a potential shift from the prior downtrend channel observed in medium-term charts. However, the broader picture remains one of consolidation, with the stock range-bound between $450 and $500 over recent months. Traders note the stock has broken the ceiling of a falling trend channel, hinting at slowing downside momentum.
Critical support levels align around the $465-$467 zone, coinciding with the 20-day moving average at $465.69 and classic pivot points S1 at $467.27 and S2 at $465.69. Deeper support from accumulated volume sits near $462. A breakdown below $463 could target $460. On the upside, resistance emerges at the pivot point of $469.25, followed by R1 at $470.83 and R2 at $472.81. Further gains may test $474-$477, where prior highs and secondary pivots cluster. These levels are pivotal for defining the range, with a close above $472 potentially signaling continuation higher.
The moving average configuration supports short-term bullish bias. The price resides above the 10-day SMA ($466.55), 20-day SMA ($465.69), 50-day SMA ($461.18), and 100-day SMA ($459.19), generating buy signals across these periods. The 5-day SMA at $471.18 acts as near-term overhead. Longer-term, the 200-day SMA/EMA near $469 provides confluence with the current price, acting as a dynamic battleground. Overall, 11 of 12 MAs flash buy, though longer-term charts show the stock below prior 50-day averages around $479, reflecting the recent pullback.
Momentum indicators present a mixed but predominantly positive picture. The RSI (14) at 56.335 indicates building strength without overextension, supporting buy conviction. MACD (12,26) shows a positive 2.77 level, with the histogram likely expanding bullishly. Stochastic (9,6) at 84.089 signals overbought conditions, cautioning for potential pullback. ADX (14) at 27.78 suggests moderate trend strength but a sell action, while Williams %R at -25 reinforces buy territory. These readings align with the recent price surge, but divergence from volume could cap upside.
Trading volume spiked notably to 2.7 million shares recently, 140% above average, coinciding with the bounce from $458 lows. This elevated activity points to institutional interest and potential liquidity grabs at support. Over the last quarter, volume has been range-bound, with spikes during breakdowns, but the latest uptick supports accumulation. Price action over the past 30 days shows a base formation near $460, with higher lows emerging, indicative of demand zones forming.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, including technical indicators, price patterns, and historical behaviors, generating actionable buy or sell signals for stocks like ISRG. These signals draw from trend recognition, momentum shifts, and pattern matching to pinpoint potential entry and exit opportunities. Traders rely on them to validate chart setups, confirm emerging trends, and refine decision-making processes amid volatile conditions. Explore these AI-powered insights to enhance your technical trading strategy.
Traders will monitor a sustained hold above $467 support for continuation toward $472 resistance, with volume confirmation essential. A failure at $465 could revisit $460 demand. Watch RSI for divergence above 60 and MACD histogram expansion. Breakout above $473 may target prior consolidation highs, while Stochastic cooldown could precede deeper retracement. Key focus remains pivot confluence and 200-day MA reaction for directional clarity.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ISRG | 1D Price Change % | ||
|---|---|---|---|---|
| ISRG | 100% | +0.06% | ||
| BSX - ISRG | 73% Closely correlated | +2.86% | ||
| SYK - ISRG | 64% Loosely correlated | +1.74% | ||
| NTRA - ISRG | 54% Loosely correlated | +2.60% | ||
| GKOS - ISRG | 51% Loosely correlated | +2.64% | ||
| PODD - ISRG | 49% Loosely correlated | +3.58% | ||
More | ||||
| Ticker / NAME | Correlation To ISRG | 1D Price Change % |
|---|---|---|
| ISRG | 100% | +0.06% |
| ISRG (2 stocks) | 99% Closely correlated | +1.46% |
| Pharmaceuticals: Other (55 stocks) | 68% Closely correlated | -0.08% |
| Pharmaceuticals (159 stocks) | 47% Loosely correlated | +0.57% |